OA CV complication treatment principle.

OA CV complication treatment principle.

• A. Lowest effective dose for shortest duration
• B. Highest tolerated dose for long duration
• C. Use only with cardiovascular risk monitoring
• D. Combination with another NSAID

Answer: (A)

In managing osteoarthritis with NSAIDs when cardiovascular risk is a concern, the priority is to balance pain relief with safety. The best approach is to use the smallest dose that provides adequate relief for the shortest possible time. This minimizes overall exposure to the drug, reducing the chance of cardiovascular complications, hypertension, edema, and other adverse effects that tend to rise with higher doses and longer use. If pain persists, explore safer alternatives or nonpharmacologic options rather than simply increasing the dose. Why the other ideas aren’t as good: using a high dose for a long period increases risk without proportional extra benefit; relying on cardiovascular risk monitoring addresses safety but doesn’t define how to dose effectively; combining NSAIDs heightens exposure and toxicity without meaningful additional pain control.

In managing osteoarthritis with NSAIDs when cardiovascular risk is a concern, the priority is to balance pain relief with safety. The best approach is to use the smallest dose that provides adequate relief for the shortest possible time. This minimizes overall exposure to the drug, reducing the chance of cardiovascular complications, hypertension, edema, and other adverse effects that tend to rise with higher doses and longer use. If pain persists, explore safer alternatives or nonpharmacologic options rather than simply increasing the dose.

Why the other ideas aren’t as good: using a high dose for a long period increases risk without proportional extra benefit; relying on cardiovascular risk monitoring addresses safety but doesn’t define how to dose effectively; combining NSAIDs heightens exposure and toxicity without meaningful additional pain control.